Abstract
Tricuspid regurgitation due to permanent pacemaker/defibrillator lead implantation (LITR) has been described more than 3 decades ago, but has come into attention recently due to the dramatic increase in the use of these devices. This entity has not been well defined and its impact on the patient and the health care system is largely unknown. This complication can have important implications. First, the presence and severity of tricuspid regurgitation in general is associated with reduced patient survival, and in the severe cases may require corrective surgery. Second, with the increasing age of the population and the expanding indications of these devices, one expects to encounter many more cases of LITR in the future. Third, this is an iatrogenic complication and therefore potentially preventable. This review discusses the prevalence, mechanisms, and risk factors of LITR as well as the management and potential strategies to prevent its occurrence.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Rogers JH, Bolling SF. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation. 2009;119:2718–25.
•• Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e1–142. These are the latest guidelines on the management of patients with valvular heart disease.
• Al-Mohaissen MA, Chan KL. Prevalence and mechanism of tricuspid regurgitation following implantation of endocardial leads for pacemaker or cardioverter-defibrillator. J Am Soc Echocardiogr. 2012;25:245–52. This paper reviewed all the pertinent publications on lead induced tricuspid regurgitation.
Nachnani GH, Gooch AS, Hsu I. Systolic murmurs induced by pacemaker catheters. Arch Intern Med. 1969;124:202–5.
Gibson TC, Davidson RC, DeSilvey DL. Presumptive tricuspid valve malfunction induced by a pacemaker lead: a case report and review of the literature. Pacing Clin Electrophysiol. 1980;3:88–95.
Fishenfeld J, Lamy Y. Laceration of the tricuspid valve by a pacemaker wire. Chest. 1972;61:697–8.
• Kim JB, Spevack DM, Tunick PA, et al. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study. J Am Soc Echocardiogr. 2008;21:284–7. This study contained the largest patient size and showed a high incidence of tricuspid regurgitation following implantation of an endocardial lead, but this was a retrospective study.
Paniagua D, Aldrich HR, Lieberman EH, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol. 1998;82:1130–2. A9.
Sakai M, Ohkawa S, Ueda K, et al. Tricuspid regurgitation induced by transvenous right ventricular pacing: echocardiographic and pathological observations. J Cardiol. 1987;17:311–20.
Leibowitz DW, Rosenheck S, Pollak A, et al. Transvenous pacemaker leads do not worsen tricuspid regurgitation: a prospective echocardiographic study. Cardiology. 2000;93:74–7.
Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol. 2005;45:1672–5.
Kucukarslan N, Kirilmaz A, Ulusoy E, et al. Tricuspid insufficiency does not increase early after permanent implantation of pacemaker leads. J Card Surg. 2006;21:391–4.
• Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J. 2008;72:1465–70. This study suggested a potential role of 3-dimensional echocardiography in the evaluation of lead induced tricuspid regurgitation.
Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol. 2009;32:S135–7.
Vaturi M, Kusniec J, Shapira Y, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr. 2010;11:550–3.
Alizadeh A, Sanati HR, Haji-Karimi M, Yazdi AH, Rad MA, Haghjoo M, et al. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing. Europace. 2011;13:1587–90.
Okura H, Takada Y, Yamabe A, et al. Prevalence and correlates of physiological valvular regurgitation in healthy subjects. Circ J. 2011;75:2699–704.
Eleid MF, Blauwet LA, Cha YM, et al. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol. 2012;59:813–8.
Postaci N, Ekşi K, Bayata S, et al. Effect of the number of ventricular leads on right ventricular hemodynamics in patients with permanent pacemaker. Angiology. 1995;46:421–4.
Robboy SJ, Harthorne JW, Leinbach RC, et al. Autopsy findings with permanent pervenous pacemakers. Circulation. 1969;39:495–501.
Chen TE, Wang CC, Chern MS, et al. Entrapment of permanent pacemaker lead as the cause of tricuspid regurgitation. Circ J. 2007;71:1169–71.
Morgan DE, Norman R, West RO, et al. Echocardiographic assessment of tricuspid regurgitation during ventricular demand pacing. Am J Cardiol. 1986;58:1025–9.
Becker AE, Becker MJ, Claudon DG, et al. Surface thrombosis and fibrous encapsulation of intravenous pacemaker catheter electrode. Circulation. 1972;46:409–12.
Huang TY, Baba N. Cardiac pathology of transvenous pacemakers. Am Heart J. 1972;83:469–74.
Pothineni KR, Duncan K, Yelamanchili P, et al. Live/real time 3-dimensional transthoracic echocardiographic assessment of tricuspid valve pathology: incremental value over the 2-dimensional technique. Echocardiography. 2007;24:541–52.
Badano LP, Agricola E, Perez de Isla L, et al. Evaluation of the tricuspid valve morphology and function by transthoracic real-time 3-dimensional echocardiography. Eur J Echocardiogr. 2009;10:477–84.
Bhave NM, Ward RP. Echocardiographic assessment and clinical management of tricuspid regurgitation. Curr Cardiol Rep. 2011;13:258–64.
Nucifora G, Badano LP, Allocca G, et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time 3-dimensional echocardiography. Echocardiography. 2007;24:649–52.
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405–9.
McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674–85.
Navia JL, Nowicki ER, Blackstone EH, et al. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg. 2010;139:1473–82.
Conflict of Interest
Maha A. Al-Mohaissen declares that he has no conflict of interest.
Kwan Leung Chan declares that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Echocardiography
Rights and permissions
About this article
Cite this article
Al-Mohaissen, M.A., Chan, K.L. Tricuspid Regurgitation Following Implantation of a Pacemaker/Cardioverter-Defibrillator. Curr Cardiol Rep 15, 357 (2013). https://doi.org/10.1007/s11886-013-0357-3
Published:
DOI: https://doi.org/10.1007/s11886-013-0357-3